Gene polymorphism of apolipoprotein AI, the major protein of high density lipoprotein in predicting stroke risk among white and black subjects

Stroke

Volumn 24, Issue 12, 1993, Pages I-26-I-30

  Yatsu, F M ^a   Kasturi, R ^a   Alam, R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Genetics; Racial differences; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; CAROTID ARTERY OBSTRUCTION; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; STROKE;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN A-I; CAUCASOID RACE; CEREBROVASCULAR DISORDERS; FEMALE; FORECASTING; GENOTYPE; HUMAN; LIPOPROTEINS, HDL; MALE; MIDDLE AGE; NEGROID RACE; PHENOTYPE; POLYMORPHISM (GENETICS); RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0027370576     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Levy RI, Feinleib M. Risk factors for coronary artery disease and their management. In Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1984;2:1205-1234.
2. Miller GJ, Miller NE. Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet. 1975; 1:16-19.
3. Avogaro P, Bittolo Bon G, Cazzolato G, Rorai E. Relationship between apolipoproteins in survivors of myocardial infarction. Atherosclerosis. 1980;37:69-76.
4. Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR, Dinh DM, Mao SJT. apolipoprotein A-I as a marker of angiographically assessed coronary artery disease. N Engl J Med. 1983;309:385-389.
5. Schaefer EJ. Clinical, biochemical and genetic features in familial disorders of high density lipoprotein deficiency. Arteriosclerosis. 1984;4:303-322.
6. Vergani C, Bettale G. Familial hypoalphalipoproteinemia. Clin ChimActa. 1981;114:45-52.
7. Daniels SR, Bates S, Lukin RR, Benton C, Third J, Glueck CJ. Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke. Stroke. 1982;13:360-365.
8. Glueck CJ, Daniels SR, Bates S, Benton C, Tracy T, Third JLHC. Pediatric victims of unexplained stroke and their families: familial lipid and lipoprotein abnormalities. Pediatrics. 1982;69:308-316.
9. Fredrickson DS. The inheritance of high density lipoprotein deficiency (Tangier disease). J Clin Invest. 1964;43:228-236.
10. Schaefer EJ, Zech LA, Schwartz DS, Brewer HB Jr. Coronary heart disease prevalence and other clinical features in familial high density lipoprotein deficiency (Tangier disease). Ann Intern Med. 1980;93:261-266.
11. Carlson LA. Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinemia: clinical and laboratory studies in two afflicted families. Eur J Clin Invest. 1982;12:41-53.
12. Norum KR, Gjone E. Familial plasma lecithin:cholesterol acetyl-transferase deficiency: biochemical study of a new inborn error of metabolism. Scand J Clin Lab Invest. 1967;20:231-243.
13. Schaefer EJ, Ordovas JM, Law SW, Ghiselli G, Kashyap ML, Shrivastava L, Heaton WH, Albers JJ, Connor WE, Lindgren FT, Lemeshev Y, Segrest JP, Brewer HB. Familial apolipoprotein A-I and C-III deficiency, variant II. J Lipid Res. 1985;26:1089-1101.
14. Schaefer EJ, Heaton WH, Wetzel MG, Brewer HB Jr. Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis. 1982;2:16-26.
15. Norum RA, Lakier JB, Goldstein S, Angel A, Goldberg RB, Block WD, Noffze DK, Dolphin PJ, Edelglass J, Bogorad DD, Alaupovic P. Familial deficiency of apolipoproteins A-I and C-III and precocious coronary artery disease. N Engl J Med. 1982;306:1513-1519.
16. Karathanasis SK, McPherson J, Zannis VI, Breslow JL. Linkage of human apolipoproteins AI and CIII genes. Nature. 1983;304:371-373.
17. Karathanasis SK. apolipoprotein multigene family: tandem organization of apolipoproteins AI, CIII and AIV genes. Proc Natl Acad Sci USA. 1985;82:6374-6378.
18. Elshourbagy NA, Walker DB, Bogusky MS, Gordon JI, Taylor JM. The nucleotide and derived amino acid sequence of human apolipoprotein AIV mRNA and the close linkage of its gene to the genes of apolipoprotein AI and CIII. J Biol Chem. 1986;261:1998-2002.
19. Bruns GAP, Karathanasis SK, Breslow JL. Human apolipoprotein AI-CIII gene complex is located on chromosome 11. Arteriosclerosis. 1984;4:97-102.
20. Law SW, Gray G, Brewer AB, Sukaguchi A-Y, Naylor SL. Human apolipoprotein A-I and C-III genes reside in the p11-q13 region of chromosome 11. Biochem Biophys Res Commun. 1984;118:934-942.
21. Cheung P, Kao FY, Law ML, Jones C, Puck TT, Chan L. Isolation of the structural gene for human apolipoprotein AI on the long arm of human chromosome 11. Proc Natl Acad Sci USA. 1984; 81:508-511.
22. Humphries. DNA polymorphisms of the apolipoprotein genes their use in investigation of the genetic component of hyperlip-idemia and atherosclerosis. Atherosclerosis. 1988;72:89-108.
23. Antonasakis SE, Oettgen P, Chakravarti A, Halloran SL, Hudson RR, Feisee L, Karathanasis SK. DNA polymorphism haplotypes of the human apolipoprotein apo Al-apo C3-apo A4 gene cluster. Hum Genet. 1988;80:265-273.
24. Ordovas JM, Schaefer EJ, Salem D, Ward RH, Glueck CJ, Vergani C, Wilson PWF, Karathanasis SK. apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med. 1986;314:671-677.
25. Karathanasis SK, Oettgen P, Haddad IA, Antonarakis SE. Structure, evolution and polymorphisms of the human apolipoprotein A4 gene. Proc Natl Acad Sci USA. 1986;83:8457-8461.
26. Cohen T, Karathanasis SK, Kazazian HH Jr, Antonarakis SE. DNA polymorphic sites in the human apo AI-CIII-AIV cluster: Taq I and Ava I. Nucleic Acids Res. 1986;14:1924-1928.
27. Coleman RT, Gonzalez PA, Funke H, Assmann G, Levy-Wilson B, Frossard PM. Polymorphism in the apolipoprotein AI-CIII gene complex. Mol Biol Med. 1986;3:213-228.
28. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE. DNA polymorphism adjacent to human apoprotein A-I gene: relation to hypertriglyceridaemia. Lancet. 1983;1:444-446.
29. Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, Jowett NI, Baralle FE, Galton DJ. Deoxyribonucleic acid polymorphism in the apolipoprotein A-I-CIII gene cluster: association with hypertriglyceridaemia. J Clin Invest. 1985;76:1090-1095.
30. Kessling AM, Horsthemke B, Humphries SE. A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidemic and normal individuals. Clin Genet. 1985;28:296-306.
31. Kessling AM, Rajput J, Bainton D, Scott J, Miller N, Baker F, Humphries SE. DNA polymorphisms of the apolipoprotein AII and AI-CIII-AIV genes: a study in men selected for differences in high density lipoprotein cholesterol concentration. Am J Hum Genet. 1988;42:458-467.
32. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Maenpaa H, Malkonen M, Manttari M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, Nikkila EA. Helsinki Heart Study: primary prevention trial with gemfibrozil in middle aged men with dyslipi-demia: safety of treatment, changes in risk factors and incidence of coronary heart disease. N Engl J Med. 1987;317:1237-1245.
33. American Heart Association committee report. Rationale of the diet-heart statement of the American Heart Association. Circulation. 1982;65:839-854.
34. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity and risk of stroke. The Framingham Study. JAMA. 1981;245:1225-1229.
35. Keys A. Coronary heart disease in seven countries. Circulation. 1970;41(suppl 1):1-8.
36. Skekelle RB, Shryock AM, Paul O, Lepper M, Stamler J, Liu S, Raynor WJ. Diet, serum cholesterol and death from coronary heart disease: the Western Electric study. N Engl J Med. 1981;304:65-70.
37. Astrup P, Kjeldren K. Carbon monoxide, smoking and atherosclerosis. Med Clin North Am. 1974;58:323-350.
38. Abbott RD, Yin Y, Reed DM, Yano K. Risk of stroke in male cigarette smokers. N Engl J Med. 1986;315:717-720.
39. Grethe ST. Cigarette smoking, lipids, lipoproteins and extracranial carotid artery atherosclerosis. Mayo Clin Proc. 1991;66:327-331.
40. Bihari-varga M, Szekely J, Gruber E. Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease: the influence of various risk factors. Atherosclerosis. 1981;40:337-345.
41. Murai A, Tanaka T, Miyamara T, Kameyama M. Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke. 1981;12:167-172.
42. Nubiola AR, Masana L, Masdeu S, Rubies-Prat J. High density lipoprotein cholesterol in cerebrovascular disease. Arch Neurol. 1981;38:468-472.
43. Rossner S, Kjellin KG, Mettinger KL, Siden A, Soderstrom CE. Normal serum cholesterol but low high density lipoprotein cholesterol concentrations in young patients with ischemic cerebrovascular disease. Lancet. 1978;1:577-579.
44. Sirtori CR, Gianfranceschi G, Gritti I, Nappi G, Brambilla G, Paoletti P. Decreased levels of high-density lipoprotein cholesterol levels in male patients with transient ischemic attacks. Atherosclerosis. 1979;30:205-211.
45. Taggart H, Sout RW. Reduced high density lipoprotein in stroke: relationship with elevated triglyceride and hypertension. Eur J Clin Invest. 1979;9:219-221.
46. Gordon T, Kannel WB, Castelli WP, Bawber TR. Lipoproteins, cardiovascular disease and death: the Framingham study. Arch Intern Med. 1981;141:1128-1131.
47. Wolf PA, Kannel WB, Verter J. Current status of risk factors for stroke. Neurol Clin. 1983;1:312-344.
48. Grotta JC, Yatsu FM, Pettigrew LC, Rhoades H, Bratina P, Vital D, Alam R, Earls R, Picone C. Prediction of carotid stenosis progression by lipid and hematologic measurements. Neurology. 1989;39:1325-1331.
49. Lipid Research Clinics Program: Manual of Laboratory Operations, Volume 1: Lipid and Lipoprotein Analysis. Bethesda, Md: 1975; US Depart of Health, Education, and Welfare publication NIH 75-628.
50. Bass F, Bikker H, van Ommen GB, de Vijldes JJM. Unusual scarcity of restriction site polymorphism in the human thyro-globulin gene: a linkage study suggesting autosomal dominance of a defective thyroglobulin allele. Hum Genet. 1984;67:301-305.
51. Blin N, Stafford DN. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acid Res. 1976; 3:2303-2308.
52. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98:503-517.
53. Karathanasis SK, Zannis VI, Breslow JL. Isolation and characterization of the human apolipoprotein AI gene. Proc NatlAcad Sci USA. 1983;80:6147-6151.
54. Nikkila EA, Taskinen MR, Sane T. Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism. Am Heart J. 1987;113:543-548.
55. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med. 1989;321:1311-1316.
56. Breslow JL. apolipoprotein genetic variation and human disease. PhysiolRev. 1988;68:85-132.
57. Anderson RA, Wallace RB. apolipoprotein AI linked genetic polymorphisms associated with high density lipoprotein levels. Clin Res. 1985;33:15. Abstract.
58. Anderson RA, Benda TJ, Wallace RB, Eliason SL, Lee J, Burns TL. Prevalence and associations of apolipoprotein AI linked DNA polymorphisms: results from a population study. Genet Epidemiol. 1986;3:385-397.
59. Anderson RA, Eliason SL. apolipoprotein AI gene locus haplotypes and HDL cholesterol levels. Clin Res. 1986;34:889. Abstract.
60. Henderson HE, London SV, Michie J, Berger GMB. Association of a DNA polymorphism in the apolipoprotein CIII gene with diverse hyperlipidaemic phenotypes. Hum Genet. 1987;75:62-65.
61. Hayden MR, Kirk H, Clark C, Frohlich J, Rabkin S, McLeod R, Hewitt J. DNA polymorphisms in and around the apo AI-CIII genes and genetic hyperlipidemias. Am J Hum Genet. 1987;40:421-430.
62. Aalto-Setala K, Kontula K, Sane T, Nieminen M, Nikkila E. DNA polymorphisms of apolipoprotein AI/CIII and insulin genes in familial hypertriglyceridemia and coronary heart disease. Atherosclerosis. 1987;66:145-152.